Moderna Increases Minimum Supply Of Coronavirus Vaccine Doses For 2021
Company Still Anticipates Up To 1 Billion Doses
The company’s announcement that it would supply at least 600 million doses of mRNA-1273 came as US vaccination rates have fallen far short of expectations.
You may also be interested in...
Moderna is speculated to be in talks with Indian firms, including Wockhardt and a Tata group company, for manufacturing and/or marketing its COVID-19 vaccine. A deal in India could help the company meet its obligation to supply COVAX but Moderna is likely to choose its partner carefully.
Moderna has received $2.8bn for advance purchase agreements for its COVID-19 vaccine, with much more to follow. Management outlined some initial financial updates for investors.
Moderna will give its coronavirus vaccine to employees immediately, while Pfizer will wait until workers are eligible under prioritization guidelines.